AI & MLNews

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry 

Raj Gondhali, AVP &Head of Clinical Solutions, Hexaware

The collaboration brings together Hexaware’s deep domain expertise and Abluva’s groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safelyand in compliance with industry regulations 

Hexaware Technologies, a provider of IT services and solutions, today entered into a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware’s deep domain expertise and Abluva’s Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safelyand in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment—without hindering innovation.

 “This collaboration is pivotal, combining our expertise in global clinical solutions with Abluva’s pioneering agentic security technology to ensure enhanced AI safety, compliance, and operational efficiency as our clients adopt next-generation AI.” 

– Raj Gondhali, AVP &Head of Clinical Solutions, Hexaware   

The key highlights of the partnership are: 

  • Real-time Agent Governance: Abluva’s Secure Intelligence Plane enforces critical controls like purpose binding, role-based context augmentation, data masking, and tooling control to prevent unauthorized actions. 
  • Comprehensive Agent Life Cycle Security: Security protocols to protect sensitive data span the entire Agent lifecycle, including fine-tuning, RetrievalAugmented Generation (RAG), and prompting stages. This provides advanced visibility and targeted safeguards specifically designed for agent-driven architectures in clinical and research settings. 
  • Autonomous Threat Mitigation and Self-Healing: Abluva’s patent-pending “self-healing” capability allows the system to automatically detect and respond to unforeseen or anomalous agent behaviors in real-time, reducing risks associated with agent autonomy. 
  • Enhanced Compliance and Privacy for AI: The solution ensures agent activities comply with industry standards like HIPAA and GDPR, and internal governance policies,through embedded governance and audit features, addressing crucial aspects of data privacy. 

“We are thrilled to partner with Abluva to implement the most secure agentic AI solutions for large sponsors and CROs,” said, Raj Gondhali, AVP &Head of Clinical Solutions, Hexaware. “This collaboration is pivotal, combining our expertise in global clinical solutions with Abluva’s pioneering agentic security technology to ensure enhanced AI safety, compliance, and operational efficiency as our clients adopt next-generation AI.” 

“By combining Hexaware’s global reach with our novel research-based technology for securing autonomous agents, we are committed to providing comprehensive and integrated solutions that enable safe AI adoption.”

 – Raj Darji, CEO at Abluva 

Raj Darji, CEO at Abluva, echoed similar sentiments: “We are excited to announce our partnership with Hexaware, a global systems integration specialist renowned for its Life Sciences expertise. This collaboration marks a significant milestone for Abluva as we aim to deliver value and innovative solutions in agentic AI security. By combining Hexaware’s global reach with our novel research-based technology for securing autonomous agents, we are committed to providing comprehensive and integrated solutions that enable safe AI adoption.” 

Amit Gautam, CTO at Abluva, added, “Our partnership with Hexaware enables us to extend our expertise in agentic AI security to a broader market, addressing the critical need for robust governance in AI-driven enterprises. By integrating our Secure Intelligence Plane with Hexaware’s capabilities, we can deliver sophisticated, real-time governance solutions tailored to secure autonomous AI agents in complex life sciences environments.” 

This partnership underlines Hexaware’s commitment to next-generation cloud and AI platforms, and Abluva’s leadership in research-driven, agentic securityinnovations. Together, they empower life sciences enterprises to unlock GenAI’s full potential—securely, at scale 

 
Hexaware is a global technology and business process services company. Every day, Hexawarians wake up with a singular purpose: to create smiles through great people and technology. With offices across the world, we empower enterprises worldwide to realize digital transformation at scale and speed by partnering with them to build, transform, run, and optimize their technology and business processes. 

Abluva stands at the forefront of data security, pioneering research-driven technologies to address today’s most pressing data challenges. We are dedicated to building a secure data plane that enables fine-grained access control and robust privacy across diverse data sources. Our innovations extend to advanced protection for agents and generative AI, alongside groundbreaking data and intent-driven breach discovery. Abluva’s solutions empower organizations to strengthen their compliance, bolster their security posture, and accelerate innovation through the secure democratization of data and intelligence.  

Related posts

Get My Parking Launches ‘Enable’ – An IoT based Smart Parking Solution

SME Channels

Trend Micro Embarks on Risk to Resilience World Tour, Covering 120 Cities

SME Channels

Verizon Business expands security portfolio with new solutions to help combat cybercrime

SME Channels

Leave a Comment

x